| __timestamp | Jazz Pharmaceuticals plc | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 675200000 |
| Thursday, January 1, 2015 | 449119000 | 771800000 |
| Friday, January 1, 2016 | 502892000 | 1205500000 |
| Sunday, January 1, 2017 | 544156000 | 1146500000 |
| Monday, January 1, 2018 | 683530000 | 1125800000 |
| Tuesday, January 1, 2019 | 736942000 | 1166100000 |
| Wednesday, January 1, 2020 | 854233000 | 1175500000 |
| Friday, January 1, 2021 | 1451683000 | 1111400000 |
| Saturday, January 1, 2022 | 1416967000 | 1210100000 |
| Sunday, January 1, 2023 | 1343105000 | 1274600000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, operational efficiency is paramount. Jazz Pharmaceuticals plc and Perrigo Company plc, two industry stalwarts, have demonstrated contrasting trends in their Selling, General, and Administrative (SG&A) expenses over the past decade. From 2014 to 2023, Jazz Pharmaceuticals saw a staggering 231% increase in SG&A expenses, peaking in 2021. This surge reflects their aggressive expansion and investment in operational capabilities. Conversely, Perrigo Company maintained a more stable trajectory, with a modest 89% increase over the same period, indicating a focus on steady growth and cost management. By 2023, Perrigo's SG&A expenses were approximately 5% higher than Jazz's, highlighting their commitment to maintaining a lean operational model. These insights underscore the strategic choices each company has made in navigating the complexities of the pharmaceutical market.
Operational Costs Compared: SG&A Analysis of Eli Lilly and Company and Perrigo Company plc
Operational Costs Compared: SG&A Analysis of Novartis AG and Perrigo Company plc
Selling, General, and Administrative Costs: Amgen Inc. vs Jazz Pharmaceuticals plc
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Breaking Down SG&A Expenses: argenx SE vs Perrigo Company plc
Walgreens Boots Alliance, Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Vericel Corporation Trends and Insights
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs Perrigo Company plc
Breaking Down SG&A Expenses: Perrigo Company plc vs Protagonist Therapeutics, Inc.